Lung-targeting lipid nanoparticles with CRISPR components successfully treat cystic fibrosis mouse models
Date | 18th, Jun 2024 |
---|---|
Source | Phys.org - Scientific News Websites |
DESCRIPTION
A team of medical researchers from the University of Texas Southwestern Medical Center, Case Western Reserve University School of Medicine and ReCode Therapeutics has developed a way to send gene-editing tools to the lungs to repair the faulty gene associated with cystic fibrosis.